A COMPARATIVE STUDY ON THE EFFECTIVENESS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN RECEPTOR BLOCKERS (ARBs) IN DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS Original Article
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
View PDFchevron_right
Comparison of Effects of ACEIs and ARBs on Albuminuria and Hyperkalemia in Indonesian Hypertensive Type 2 Diabetes Mellitus Patients
Pukovisa Prawiroharjo
International Journal of Hypertension
View PDFchevron_right
Progression of renal disease--can we forget about inhibition of the renin-angiotensin system? Authors' reply
Johannes Mann
Nephrology Dialysis Transplantation, 2006
View PDFchevron_right
Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure
David Packham
Nephrology Dialysis Transplantation, 2004
View PDFchevron_right
Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
Johannes Mann
Diabetologia, 2011
View PDFchevron_right
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
Kasper Rossing
Kidney International, 2003
View PDFchevron_right
Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis
Panagiotis Stafylas
American Journal of Hypertension, 2008
View PDFchevron_right
Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
em yunir
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
View PDFchevron_right
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
Francesco Schena
The Lancet, 1999
View PDFchevron_right
Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?
Chelsea Mannebach, Eva Vivian
Drugs in Context, 2013
View PDFchevron_right
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
David Leehey
New England Journal of Medicine, 2013
View PDFchevron_right
Combination Therapy of Angiotensin Converting Enzyme Inhibitor and Angiotensin AT1 Receptor Antagonist in Diabetic Nephropathy
Todd MacLaughlan
Hong Kong Journal of Nephrology, 2007
View PDFchevron_right
Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Debbie Cohen
Journal of the American Society of …, 2009
View PDFchevron_right
ACE Inhibitors and ARBs: Are They Better Than Other Agents to Slow Nephropathy Progression?
George Bakris
The Journal of Clinical Hypertension, 2007
View PDFchevron_right
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro-and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials
Giorgio Gentile
View PDFchevron_right
A COMPARATIVE STUDY ON THE EFFECTIVENESS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN RECEPTOR BLOCKERS (ARBs) IN DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS
Pharmacist anantha
International Journal of Pharmacy and Pharmaceutical Sciences, 2016
View PDFchevron_right
Comparative Study of the Effect of Ace Inhibitors and other Antihypertensive Agents on Proteinuria in Diabetic Patients
Maximilian de Courten
The Kidney and Hypertension in Diabetes Mellitus, 1996
View PDFchevron_right
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points
Kasper Rossing
Seminars in Nephrology, 2004
View PDFchevron_right
ACE inhibitors and ARBs: Managing potassium and renal function
deris muhammad ilyas
Cleveland Clinic Journal of Medicine, 2019
View PDFchevron_right
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
George Bakris
Kidney International, 1998
View PDFchevron_right
INHIBITORS AND BLOCKERS OF RENIN-ANGIOTENSIN SYSTEM IN THE PREVENTION AND IN DELAYING THE PROGRESSION OF DIABETIC NEPHROPATHY – A COMPARATIVESTUDY
Wasim Raja
International Journal of Pharmacy Practice & Drug Research
View PDFchevron_right
The Combined Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Progressing of Kidney Disease in Patients with Type 2 Diabetes Compared to Single Administration of Each of These Two Drugs
Samaneh Khodadadi
View PDFchevron_right
Diabetic Nephropathy – is Less Best?
eva vivian
2016
View PDFchevron_right
ACE inhibitors in non-diabetic renal disease
Richard Fluck
Heart, 1994
View PDFchevron_right
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection
Ariela Benigni
American Journal of Physiology-Renal Physiology, 2010
View PDFchevron_right
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis
Lavanya Srinivasan
American Heart Journal, 2008
View PDFchevron_right
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study
Asma Khan
Vascular Health and Risk Management, 2008
View PDFchevron_right